- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 7, 2026 | 256.61M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 267.83M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 274.73M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 280.85M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 308.34M sh |
| Stock Repurchased | Q2 2026 · Mar 31, 2026 | $460M |
| Stock Repurchased | Q2 2026 · Mar 31, 2025 | $145M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | −$296.96M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | −$231.74M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $1.79B |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $644.59M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $260.29M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $42.97M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $986.16M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $1.38B |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $2.18B |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $1.89B |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $2.02B |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $1.76B |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $133.07M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $315.77M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $1.93B |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $1.01B |
| Current Assets | Q2 2026 · Mar 31, 2026 | $1.1B |
| Current Assets | Q2 2026 · Sep 30, 2025 | $1.32B |
| Total Assets | Q2 2026 · Mar 31, 2026 | $2.91B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $3.18B |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $16.11M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $31.55M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $11.74M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $21.79M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$378.34M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$757.05M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$138.79M |
| Net Income | Q2 2026 · Mar 31, 2025 | $108M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$345.68M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$662.23M |
| Operating Income | Q2 2026 · Mar 31, 2025 | −$138.02M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $71.95M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $81.69M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $177.31M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $85.42M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $155.71M |